I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 7 studies | 21% ± 9% | |
| classical monocyte | 5 studies | 27% ± 10% | |
| pericyte | 5 studies | 21% ± 5% | |
| endothelial cell | 5 studies | 27% ± 11% | |
| smooth muscle cell | 5 studies | 18% ± 2% | |
| ciliated cell | 5 studies | 26% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 3% | |
| conventional dendritic cell | 3 studies | 33% ± 9% | |
| non-classical monocyte | 3 studies | 23% ± 3% | |
| myofibroblast cell | 3 studies | 17% ± 2% | |
| epithelial cell | 3 studies | 43% ± 8% | |
| natural killer cell | 3 studies | 19% ± 2% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 1% |
